SCHEMBL9045401

SCHEMBL9045401

COc1cccc(OC)c1Cc1c(O)ncnc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
TP53 P04637 2/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
ALOX12 P18054 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NQO1 P15559 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
TSHR P16473 1/20 0.39
GAA P10253 3/20 0.38
GFER P55789 1/20 0.38
HTR1A P08908 1/20 0.37
ADRA1D P25100 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5250993 0.80 CA2 (0.55) ALDH1A1TP53MAPTHPGDKDM4E
SCHEMBL9046597 0.79 ALDH1A1 (0.56) ALDH1A1MAPTHPGDKDM4ELMNA
SCHEMBL3507559 0.73 HTR1A (0.49) ALDH1A1TP53MAPTHPGDKDM4E
SCHEMBL9044071 0.72 APLNR (0.49) ALDH1A1KDM4ELMNACYP3A4ALOX15
SCHEMBL3429487 0.71 EGFR (0.51) ALDH1A1TP53MAPTHPGDKDM4E
SCHEMBL5632559 0.69 ALDH1A1 (0.48) ALDH1A1TP53MAPTHPGDKDM4E
SCHEMBL505777 0.68 CA1 (0.50) ALDH1A1TP53MAPTHPGDKDM4E
SCHEMBL11158816 0.68 CA1 (0.50) ALDH1A1TP53MAPTHPGDKDM4E
SCHEMBL23499986 0.67 CA1 (0.44) ALDH1A1TP53MAPTHPGDKDM4E
SCHEMBL3728677 0.67 LTA4H (0.52) ALDH1A1MAPTKDM4EMAPK1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed